Triglav Skladi, D.O.O. Biogen Inc. Transaction History
Triglav Skladi, D.O.O.
- $1.36 Billion
- Q2 2025
A detailed history of Triglav Skladi, D.O.O. transactions in Biogen Inc. stock. As of the latest transaction made, Triglav Skladi, D.O.O. holds 18,027 shares of BIIB stock, worth $2.88 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
18,027
Previous 18,027
-0.0%
Holding current value
$2.88 Million
Previous $2.47 Billion
99.91%
% of portfolio
0.17%
Previous 0.21%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,020Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.76 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.53 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.32 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.19 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$767 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...